Search

Your search keyword '"RIZZELLO, F."' showing total 97 results
Start Over Author "RIZZELLO, F." Journal digestive and liver disease
97 results on '"RIZZELLO, F."'

1. PC.01.9 HYPOMETHYLATION OF LINE-1 IN SMALL BOWEL CARCINOMAS AND COELIAC DISEASE

Author

Guerini, C., primary, Bianchi, P.I., additional, Libera, L., additional, Vanoli, A., additional, Arpa, G., additional, Aronico, N., additional, Furlan, D., additional, Grillo, F., additional, Nesi, G., additional, Sampietro, G., additional, Ardizzone, S., additional, Fociani, P., additional, Fiocca, R., additional, Latella, G., additional, Sessa, F., additional, D'Errico, A., additional, Malvi, D., additional, Mescoli, C., additional, Rugge, M., additional, Ferrero, S., additional, Poggioli, G., additional, Rizzello, F., additional, Macciomei, M., additional, Santini, D., additional, Volta, U., additional, De Giorgio, R., additional, Caio, G., additional, Calabro, A., additional, Ciacci, C., additional, D'Armiento, M., additional, Rizzo, A., additional, Solina, G., additional, Tonelli, F., additional, Villanacci, V., additional, Cannizzaro, R., additional, Canzonieri, V., additional, Florena, A., additional, Biancone, L., additional, Monteleone, G., additional, Caronna, R., additional, Ciardi, A., additional, Elli, L., additional, Caprioli, F., additional, Vecchi, M., additional, D'Inca, R., additional, Zingone, F., additional, D'Odorico, A., additional, Oreggia, B., additional, Reggiani Bonetti, L., additional, Astegiano, M., additional, Cantoro, L., additional, Papi, C., additional, Sandri, G., additional, Silano, M., additional, Usai, P., additional, Perfetti, V., additional, Quaquarini, E., additional, Giannone, A., additional, Orlandi, A., additional, Barresi, V., additional, Ciccocioppo, R., additional, Amodeo, G., additional, Biletta, E., additional, and Di Sabatino, A., additional

Published
2023
Full Text
View/download PDF

2. OC.14.6 ATTITUDES TOWARDS VACCINATIONS IN AN ITALIAN COHORT OF IBD PATIENTS

Author

Costantino, A., primary, Michelon, M., additional, Noviello, D., additional, Leone, S., additional, Aloi, M., additional, Armuzzi, A., additional, Bossa, F., additional, Ficari, F., additional, Manguso, F., additional, Mocci, G., additional, Orlando, A., additional, Pironi, L., additional, Radice, S., additional, Rizzello, F., additional, Tongiorgi, A., additional, Costantino, C., additional, Vecchi, M., additional, and Caprioli, F.A., additional

Published
2023
Full Text
View/download PDF

3. AF.49 DETERMINANTS OF COVID-19 VACCINE HESITANCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): RESULTS OF A NATIONAL SURVEY OF THE ITALIAN IBD PATIENTS’ ASSOCIATION (AMICI ONLUS)

Author

Costantino, A., primary, Noviello, D., additional, Conforti, F.S., additional, Aloi, M., additional, Armuzzi, A., additional, Bossa, F., additional, Ficari, F., additional, Leone, S., additional, Manguso, F., additional, Mocci, G., additional, Orlando, A., additional, Pironi, L., additional, Radice, S., additional, Rizzello, F., additional, Tongiorgi, A., additional, Costantino, C., additional, Vecchi, M., additional, and Caprioli, F., additional

Published
2021
Full Text
View/download PDF

7. OC.12.6 PREVALENCE OF ANAEMIA IN INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS OF THE OBSERVATIONAL ITALIAN MULTICENTRE IG-IBD STUDY RIDART 1

Author

Bergamaschi, G., primary, Lenti, M.V., additional, Giuffrida, P., additional, Soriano, S., additional, D'Incà, R., additional, Astegiano, M., additional, Aronico, N., additional, Fries, W., additional, Rizzello, F., additional, Ciacci, C., additional, Bossa, F., additional, Orlando, A., additional, Ghigliazza, G., additional, Castiglione, F., additional, Milla, M., additional, Nardelli, S., additional, Principi, M.B., additional, Scribano, M.L., additional, Ricci, C., additional, Mazzucco, D., additional, Riegler, G., additional, Bassotti, G., additional, Buda, A., additional, Neri, M., additional, Bodini, G., additional, Monica, F., additional, Manca, A., additional, Villa, E., additional, Comberlato, M., additional, Saibeni, S., additional, Bezzio, C., additional, Sidoli, L., additional, Cannatelli, R., additional, Neve, V., additional, Vernia, P., additional, Pieraccini, A., additional, Testa, A., additional, Mengoli, C., additional, Rizzuto, G., additional, Fontana, R., additional, Iovino, P., additional, Valerii, C., additional, Pinto Vraca, T., additional, Ponzo, E., additional, Caccaro, R., additional, Corazza, G.R., additional, and Di Sabatino, A., additional

Published
2020
Full Text
View/download PDF

10. PC.01.4 PREVALENCE OF ANAEMIA IN INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS OF THE OBSERVATIONAL ITALIAN MULTICENTRE IG-IBD STUDY RIDART 1

Author

Bergamaschi, G., primary, Giuffrida, P., additional, D'Incà, R., additional, Lenti, M.V., additional, Astegiano, M., additional, Aronico, N., additional, Fries, W., additional, Rizzello, F., additional, Cococcia, S., additional, Ciacci, C., additional, Bossa, F., additional, Orlando, A., additional, Ghigliazza, G., additional, Castiglione, F., additional, Milla, M., additional, Nardelli, S., additional, Principi, M.B., additional, Scribano, M.L., additional, Ricci, C., additional, Mazzucco, D., additional, Riegler, G., additional, Bassotti, G., additional, Buda, A., additional, Neri, M., additional, Bodini, G., additional, Monica, F., additional, Manca, A., additional, Villa, E., additional, Masotti, M., additional, Comberlato, M., additional, Saimbeni, S., additional, Sidoli, L., additional, Cannatelli, R., additional, Neve, V., additional, Vernia, P., additional, Pieraccini, A., additional, Testa, A., additional, Mengoli, C., additional, Rizzuto, G., additional, Fontana, R., additional, Iovino, P., additional, Valerii, C., additional, Vraca, T. Pinto, additional, Ponzo, E., additional, Caccaro, R., additional, Corazza, G.R., additional, and Di Sabatino, A., additional

Published
2019
Full Text
View/download PDF

18. OC.14.9: Logistic and Scientific Needs for Professional Updating for Physicians Managing Inflammatory Bowel Disease. A Survey of the Italian Group for Inflammatory Bowel Disease (IG-IBD)

Author

Saibeni, S., primary, Bezzio, C., additional, Armuzzi, A., additional, Bossa, F., additional, Calabrese, E., additional, Caprioli, F., additional, Daperno, M., additional, Mocciaro, F., additional, Orlando, A., additional, Papi, C., additional, Rispo, A., additional, and Rizzello, F., additional

Published
2017
Full Text
View/download PDF

19. P.05.3: Limitations and Difficulties in using Anti-TNF Alpha Agents in Inflammatory Bowel Disease. A Survey of the Italian Group for Inflammatory Bowel Disease (IG-IBD)

Author

Saibeni, S., primary, Bezzio, C., additional, Armuzzi, A., additional, Bossa, F., additional, Calabrese, E., additional, Caprioli, F., additional, Daperno, M., additional, Mocciaro, F., additional, Orlando, A., additional, Papi, C., additional, Rispo, A., additional, and Rizzello, F., additional

Published
2017
Full Text
View/download PDF

21. OC.11.3 EARLY POST-OPERATIVE ENDOSCOPIC RECURRENCE IN CROHN'S DISEASE: DATA FROM A LARGE PROSPECTIVE ITALIAN MULTICENTER COHORT (AN IG-IBD STUDY)

Author

Orlando, A., primary, Mocciaro, F., additional, Scimeca, D., additional, Rispo, A., additional, Scribano, M.L., additional, Testa, A., additional, Aratari, A., additional, Bossa, F., additional, Tambasco, R., additional, Angelucci, E., additional, Onali, S., additional, Cappello, M., additional, Fries, W., additional, D'Incà, R., additional, Martinato, M., additional, Castiglione, F., additional, Papi, C., additional, Annese, V., additional, Gionchetti, P., additional, Rizzello, F., additional, Vernia, P., additional, Biancone, L., additional, Kohn, A., additional, and Cottone, M., additional

Published
2013
Full Text
View/download PDF

26. OC.12.1 INTEROBSERVER AGREEMENT IN IBD SCORES REQUIRES EXPERTISE AND EDUCATION: PRELIMINARY RESULTS FROM AN ONGOING IG-IBD STUDY

Author

Daperno, M., primary, Comberlato, M., additional, Bossa, F., additional, Biancone, L., additional, Bonanomi, A., additional, Cassinotti, A., additional, Cosintino, R., additional, Lombardi, G., additional, Mangiarotti, R., additional, Orlando, A., additional, Papa, A., additional, Pica, R., additional, Rizzello, F., additional, D'Incà, R., additional, and Dincà, R., additional

Published
2012
Full Text
View/download PDF

29. OC.12.3 EARLY POST-OPERATIVE ENDOSCOPIC RECURRENCE IN CROHN'S DISEASE IN A LARGE PROSPECTIVE ITALIAN MULTICENTER COHORT

Author

Orlando, A., primary, Mocciaro, F., additional, Scimeca, D., additional, Rispo, A., additional, Scribano, M.L., additional, Testa, A., additional, Aratari, A., additional, Bossa, F., additional, Tambasco, R., additional, Angelucci, E., additional, Onali, S., additional, Cappello, M., additional, Fries, W., additional, D'Incà, R., additional, Martinato, M., additional, Castiglione, F., additional, Papi, C., additional, Annese, V., additional, Gionchetti, P., additional, Rizzello, F., additional, Vernia, P., additional, Biancone, L., additional, Perricone, G., additional, Kohn, A., additional, and Cottone, M., additional

Published
2012
Full Text
View/download PDF

31. OC.06.3 ADALIMUMAB IN ACTIVE ULCERATIVE COLITIS: A “REAL-LIFE” OBSERVATIONAL STUDY

Author

Armuzzi, A., primary, Biancone, L., additional, Daperno, M., additional, Coli, A., additional, Annese, V., additional, Ardizzone, S., additional, Balestrieri, P., additional, Bossa, F., additional, Castiglione, F., additional, Cicala, M., additional, Danese, S., additional, D'Incà, R., additional, Dulbecco, P., additional, Feliciangeli, G., additional, Fries, W., additional, Genise, S., additional, Gionchetti, P., additional, Gozzi, S., additional, Kohn, A., additional, Lorenzetti, R., additional, Milla, M., additional, Onali, S., additional, Orlando, A., additional, Papparella, L.G., additional, Pugliese, D., additional, Renna, S., additional, Ricci, C., additional, Rizzello, F., additional, Sostegni, R., additional, Guidi, L., additional, and Papi, C., additional

Published
2012
Full Text
View/download PDF

38. NEWLY DIAGNOSED NEOPLASIA IN A COHORT OF CROHN'S DISEASE PATIENTS TREATED OR UNTREATED WITH INFLIXIMAB FOLLOWED UP IN THE LONG TERM: A MULTICENTER MATCHED-PAIR STUDY

Author

Petruzziello, C., primary, Orlando, A., additional, Kohn, A., additional, Ardizzone, S., additional, Daperno, M., additional, Angelucci, E., additional, Castiglione, F., additional, D'Incà, R., additional, Papi, C., additional, Meucci, G., additional, Riegler, G., additional, Sica, G., additional, Rizzello, F., additional, Mocciaro, F., additional, Onali, S., additional, Calabrese, E., additional, Cottone, M., additional, Pallone, F., additional, and Biancone, L., additional

Published
2009
Full Text
View/download PDF

44. Chemokine expression in pouchitis

Author

Rizzello, F., primary, Uguccioni, M., additional, Amadini, C., additional, Venturi, A., additional, Morselli, C., additional, Salvatori, S., additional, Romboli, E., additional, Baggiolini, M., additional, and Campieri, M., additional

Published
2000
Full Text
View/download PDF

45. Chemokine expression in pouchitis

Author

Lammers, K.M., primary, Helwig, U., additional, Rizzello, F., additional, Uguccioni, M., additional, Amadini, C., additional, Venturi, A., additional, Palmonari, V., additional, Baggiolini, M., additional, and Campieri, M., additional

Published
2000
Full Text
View/download PDF

46. Bacteria in pouch tissue

Author

Helwig, U., primary, Swidinski, A., additional, Gionchetti, P., additional, Rizzello, F., additional, Amadini, C., additional, Lammers, K.M., additional, Campieri, M., additional, and Lochs, H., additional

Published
2000
Full Text
View/download PDF

48. Management of patients with complex perianal fistulas in Crohn's disease: Optimal patient flow in the Italian clinical reality

Author

Alessandro Armuzzi, G. Solina, Antonino Spinelli, Silvio Danese, Rachele Ciccocioppo, Antonio Rispo, Ambrogio Orlando, Fernando Rizzello, Gilberto Poggioli, Paolo Gionchetti, L. Sofo, Gaetano Luglio, Spinelli, A., Armuzzi, A., Ciccocioppo, R., Danese, S., Gionchetti, P., Luglio, G., Orlando, A., Rispo, A., Rizzello, F., Sofo, L., Solina, G., Poggioli, G., Spinelli A., Armuzzi A., Ciccocioppo R., Danese S., Gionchetti P., Luglio G., Orlando A., Rispo A., Rizzello F., Sofo L., Solina G., Poggioli G., Spinelli, A, Armuzzi, A, Ciccocioppo, R, Danese, S, Gionchetti, P, Luglio, G, Orlando, A, Rispo, A, Rizzello, F, Sofo, L, Solina, G, and Poggioli, G

Subjects
Crohn’s disease, medicine.medical_specialty, Aggressive phenotype, Stem cells, Disease, Mesenchymal Stem Cell Transplantation, Perianal fistula, Unmet needs, 03 medical and health sciences, 0302 clinical medicine, Crohn Disease, Multidisciplinary approach, Humans, Rectal Fistula, Medicine, Intensive care medicine, New therapies, Randomized Controlled Trials as Topic, Surgical treatment, Crohn's disease, Stem cell, Local practice, Hepatology, business.industry, Perianal fistulas, Gastroenterology, New therapie, Disease Management, Endoscopy, medicine.disease, Combined Modality Therapy, Clinical reality, Management, Patient flow, Biological Therapy, Italy, 030220 oncology & carcinogenesis, Quality of Life, 030211 gastroenterology & hepatology, business, Medical treatment
Abstract

Perianal fistulizing Crohn's disease (PFCD) is a common, disabling and aggressive phenotype that negatively impacts on the quality of life of affected patients. Its successful treatment is still a struggle for both physicians and patients. Significant advances in the management of this condition have occurred in the last two decades holding promise for a better future. This culminated into the concept of a collaborative multidisciplinary approach using the latest medical therapies combined with modern surgical and endoscopic techniques. Despite this, PFCD management and treatment have not been standardized yet. Thus the gastroenterologist and surgeon have to be familiar with several approaches and/or techniques. The positioning of each therapeutic option will certainly evolve with new data, but for the time being it should be driven by patient's characteristics, physician's preference and/or experience, costs and availability in local practice. Additionally, patient's perception of benefits and risks of treatment may differ from those of physicians and recognition of this difference is a starting point for difficult clinical decision-making. In this paper, a multidisciplinary group of Italian IBD experts explore and discuss current medical and surgical therapeutic options, highlighting areas of unmet needs in PFCD, with particular focus on the optimal patient flow within the Italian clinical reality.

Published
2020
Full Text
View/download PDF

49. Infliximab in the treatment of Crohn's disease: Predictors of response in an Italian multicentric open study

Author

Alessandro Lavagna, Andrea Cassinotti, Gianmichele Meucci, F. Mocciaro, C. Morselli, Daniela Scimeca, R. Sostegni, Mario Cottone, E. Angelucci, Ambrogio Orlando, R. Cosintino, Livia Biancone, Alessandra Geremia, Fernando Rizzello, Anna Kohn, Antonio Rispo, Fabrizio Bossa, Gabriele Riegler, L. Benazzato, Claudio Papi, Fabiana Castiglione, Enrico Colombo, Angelo Viscido, Orlando A, Colombo E, Kohn A, Biancone L, Rizzello F, Viscido A, Sostegni R, Benazzato L, Castiglione F, Papi C, Meucci G, Riegler G, Mocciaro F, Cassinotti A, Cosintino R, Geremia A, Morselli C, Angelucci E, Lavagna A, Rispo A, Bossa F, Scimeca D, Cottone M, ORLANDO A, COLOMBO E, KOHN A, BIANCONE L, RIZZELLO F, VISCIDO A, SOSTEGNI R, BENAZZATO L, CASTIGLIONE F, PAPI C, MEUCCI G, RIEGLER G, MOCCIARO F, CASSINOTTI A, COSINTINO R, GEREMIA A, MORSELLI C, ANGELUCCI E, LAVAGNA A, RISPO A, BOSSA F, SCIMECA D, COTTONE M, A., Orlando, E., Colombo, A., Kohn, L., Biancone, F., Rizzello, A., Viscido, R., Sostegni, L., Benazzato, Castiglione, Fabiana, C., Papi, G., Meucci, F., Mocciaro, A., Geremia, A., Rispo, D., Scimeca, and M., Cottone

Subjects
Adult, Male, medicine.medical_specialty, Fistula, Predictors of response, Age at diagnosis, Disease, Gastroenterology, Antibodies, Dose-Response Relationship, Crohn Disease, Gastrointestinal Agents, Refractory, Internal medicine, Monoclonal, medicine, Humans, infliximab.crohn's disease, Settore MED/12 - Gastroenterologia, Crohn's disease, Dose-Response Relationship, Drug, Hepatology, business.industry, Remission Induction, Smoking, Antibodies, Monoclonal, medicine.disease, Crohn's Disease Activity Index, Infliximab, Surgery, Open study, Female, Italy, Multivariate Analysis, Concomitant, Drug, business, medicine.drug
Abstract

Background. Almost 20% of patients with active Crohn's disease are refractory to conventional therapy. Infliximab is a treatment of proven efficacy in this group of patients and it is not clear which variables predict a good response. Aims. To evaluate the role of infliximab looking at the predictors of response in a large series of patients with Crohn's disease. Patients and methods. Five hundred and seventy-three patients with luminal refractory Crohn's disease (Crohn's Disease Activity Index (CDAI) > 220–400) (312 patients) or with fistulising disease (190 patients) or both of them (71 patients) were treated with a dose of 5 mg/kg in 12 Italian referral centres. The primary endpoints of the study were clinical response and clinical remission for luminal refractory and fistulising disease. We evaluated at univariable and multivariable analysis the following variables: number of infusions, sex, age at diagnosis, smoking habit, site of disease, previous surgery, extraintestinal manifestations and concomitant therapies, and type of fistulas. Results. Patients with luminal refractory disease: 322 patients (84.1%) had a clinical response and 228 (59.5%) reached clinical remission. Patients with fistulising disease: 187 patients (72%) had a reduction of 50% of the number of fistulas and in 107 (41%) a total closure of fistulas was observed. For luminal disease, single infusion (OR 0.49, 95% CI 0.28–0.86) and previous surgery (OR 0.53, 95% CI 0.30–0.93) predicted a worse response for fistulising disease. Other fistulas responded worse than perianal fistulas (OR 0.57, 95% CI 0.303–1.097). Conclusion. In Crohn's disease infliximab is effective in luminal refractory and in fistulising disease. A single infusion and previous surgery predicted a worse response in luminal disease whereas perianal fistulas predicted a better response than other type of fistulas.

Published
2005
Full Text
View/download PDF

50. Long term remission after ileorectal anastomosis in Crohn's colitis

Author

D. Sgambato, Silvio Laureti, Fernando Rizzello, Gilberto Poggioli, Paolo Gionchetti, Marco Salice, Matteo Rottoli, Francesco Manguso, Carlo Calabrese, Salice M., Rizzello F., Sgambato D., Calabrese C., Manguso F., Laureti S., Rottoli M., Poggioli G., and Gionchetti P.

Subjects
Adult, Male, medicine.medical_specialty, medicine.medical_treatment, Crohn's colitis, IBD, Disease, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Crohn Disease, Ileorectal anastomosis, Refractory, Recurrence, Internal medicine, medicine, Humans, Colitis, Colectomy, Retrospective Studies, Crohn's disease, Hepatology, Ileostomy, business.industry, Anastomosis, Surgical, Middle Aged, medicine.disease, digestive system diseases, Clinical trial, Ileorectal anastomosi, 030220 oncology & carcinogenesis, Female, Surgery, 030211 gastroenterology & hepatology, business
Abstract

Background: Crohn's disease represents a heterogeneous entity, but its location tends to be relatively stable overtime. For extensive refractory Crohn's colitis, ileorectal anastomosis after colectomy is an engaging option, since the necessity of a permanent ileostomy is avoided. Aims: In our study, the long-term outcome of two groups of patients with Crohn's colitis who underwent colectomy and ileorectal anastomosis was compared. The first group had isolated colonic Crohn's disease without rectal involvement and perianal disease, while the second group included patients who had rectal and/or ileal involvement, with or without perianal disease. Methods: Between 1996 and 2016, in a single IBD tertiary center, 80 patients with a history of colectomy and ileorectal anastomosis for refractory Crohn's colitis were retrospectively identified. Results: Recurrence of disease was diagnosed in 57/64 of patients with Crohn's colitis with rectal and/or ileal and/or perianal involvement compared with 1/16 of patients with isolated Crohn's colitis without rectal and perianal disease in a median time of recurrence of 2 years (IQR 1–6 years, minimum to maximum, 1–18 years, p < 0.001). Only 6 patients (7,5%) underwent definitive end ileostomy without proctectomy (1 in the noIRP group and 5 in the IRP group). Conclusion: Our data suggest that colectomy with ileorectal anastomosis may represent a curative option in patients with refractory isolated colitis without rectal and perianal involvement.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results